QMS Medical Allied Services Schedules Q4 & FY26 Earnings Conference Call for June 4, 2026

1 min read     Updated on 01 Jun 2026, 10:47 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

QMS Medical Allied Services Limited has announced its Q4 & FY26 Earnings Conference Call, scheduled for Thursday, June 4, 2026, at 11:00 AM IST. The call pertains to the company's financial results for the half year ended March 31, 2026, and was intimated to the National Stock Exchange of India Ltd. pursuant to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. The call will be represented by Chairman & Managing Director Mr. Mahesh Makhija and Director Compliance Mr. Mohit Tamhankar. Dial-in details are available on the company's website.

powered bylight_fuzz_icon
41879807

*this image is generated using AI for illustrative purposes only.

QMS Medical Allied Services Limited has announced the scheduling of its Q4 & FY26 Earnings Conference Call, pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call will cover the company's financial results for the half year ended March 31, 2026. The intimation was filed with the National Stock Exchange of India Ltd. and signed by Company Secretary and Compliance Officer Toral Bhadra on May 30, 2026.

Earnings Call Details

The following key details have been disclosed for the upcoming earnings conference call:

Parameter: Details
Event: Q4 & FY26 Earnings Conference Call
Date: Thursday, June 4, 2026
Time: 11:00 AM IST
Financial Period: Half year ended March 31, 2026
Regulatory Basis: Regulation 30(6), SEBI (LODR) Regulations, 2015

Management Representatives

The earnings call will feature participation from senior company leadership:

  • Mr. Mahesh Makhija — Chairman & Managing Director
  • Mr. Mohit Tamhankar — Director Compliance

Investor Relations Contact

For further information regarding the earnings call, investors and analysts may reach out to the designated investor relations contacts:

Contact: Details
Ankit Jain: ankit@stellar-ir.com
Shruti Vasani: shruti@stellar-ir.com
Contact No.: +91 22 6239 8024

Dial-in details for the conference call are available on the company's official website at www.qmsmas.com . The filing was submitted from Mumbai and is in compliance with applicable SEBI disclosure requirements.

Historical Stock Returns for QMS Medical Allied Services

1 Day5 Days1 Month6 Months1 Year5 Years
+3.23%+0.46%-2.44%-4.62%+2.09%-31.62%

What strategic initiatives is QMS Medical Allied Services planning to drive growth in FY27?

How will the company address potential market challenges in the healthcare sector over the next year?

What are the expected revenue and profit margins for the upcoming fiscal year based on current trends?

QMS Medical Allied Services
View Company Insights
View All News
like15
dislike

QMS Medical Allied Services confirms SDD compliance for FY26

1 min read     Updated on 26 May 2026, 03:13 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

QMS Medical Allied Services Limited submitted its SDD Compliance Certificate for the year ended March 31, 2026, confirming full adherence to SEBI regulations. The certification by Maharshi Ganatra & Associates verified the presence of a secure, non-tamperable database for tracking UPSI with no reported non-compliance.

powered bylight_fuzz_icon
41290996

*this image is generated using AI for illustrative purposes only.

QMS Medical Allied Services Limited has confirmed compliance with the Structured Digital Database (SDD) requirements for the financial year ended March 31, 2026. The company submitted the necessary compliance certificate to the National Stock Exchange of India Ltd., certifying that its internal systems for tracking Unpublished Price Sensitive Information (UPSI) are fully operational and secure. This adherence to regulatory standards mitigates the risk of insider trading and ensures transparency in information dissemination.

Regulatory Filing Details

The submission was made pursuant to Regulation 3(5) and 3(6) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. As the provisions of Regulation 24A of SEBI (LODR) Regulations, 2015 are not applicable to the entity, QMS Medical Allied Services was required to file the certificate within 60 days from the end of the financial year. The document was certified by M/s. Maharshi Ganatra & Associates, a Practicing Company Secretary.

Compliance Status

The certificate validates that the company maintains a non-tamperable digital database with controlled access and a comprehensive audit trail. It confirms that all UPSI disseminated during the previous quarter was captured with the necessary details, including the nature of the information and the precise date and time. The system is designed to retain records for a period of 8 years.

Key Certification Points

Compliance Parameter Status
Structured Digital Database in place Yes
Access controls defined Yes
UPSI capture for previous quarter Yes
Date and time logging Yes
Internal maintenance and audit trail Yes
Non-tamperable records (8-year retention) Yes

The certification further clarifies that the company was required to capture one event during the quarter and successfully recorded the said event. No instances of non-compliance were observed in the quarter ended March 31, 2026.

Historical Stock Returns for QMS Medical Allied Services

1 Day5 Days1 Month6 Months1 Year5 Years
+3.23%+0.46%-2.44%-4.62%+2.09%-31.62%

How will the implementation of the Structured Digital Database influence QMS Medical's operational efficiency and internal audit processes?

Could this enhanced compliance framework make QMS Medical more attractive to institutional investors seeking higher governance standards?

What specific type of UPSI event was recorded during the quarter, and does it signal potential strategic shifts for the company?

QMS Medical Allied Services
View Company Insights
View All News
like19
dislike

More News on QMS Medical Allied Services

1 Year Returns:+2.09%